Advocating the need of a systems biology approach for personalised prognosis and treatment of B-CLL patients

Hemanth Tummala, Alexey Goltsov, Hilal S. Khalil, Anne Sproul, Fiona Scott, Vanio Mitev, Nikolai Zhelev

Research output: Contribution to journalArticle

9 Downloads (Pure)

Abstract

The clinical course of B-CLL is heterogeneous. This heterogeneity leads to a clinical dilemma: can we identify those patients who will benefit from early treatment and predict the survival? In recent years, mathematical modelling has contributed significantly in understanding the complexity of diseases. In order to build a mathematical model for determining prognosis of B-CLL one has to identify, characterise and quantify key molecules involved in the disease. Here we discuss the need and role of mathematical modelling in predicting B-CLL disease pathogenesis and suggest a new systems biology approach for a personalised therapy of B-CLL patients.
Original languageEnglish
Number of pages15
JournalBioDiscovery
Volume6
Issue number4
DOIs
Publication statusPublished - 30 Dec 2012

Fingerprint

Systems Biology
Theoretical Models
Therapeutics
Survival

Cite this

Tummala, Hemanth ; Goltsov, Alexey ; Khalil, Hilal S. ; Sproul, Anne ; Scott, Fiona ; Mitev, Vanio ; Zhelev, Nikolai. / Advocating the need of a systems biology approach for personalised prognosis and treatment of B-CLL patients. In: BioDiscovery. 2012 ; Vol. 6, No. 4.
@article{42051d90afb14c2882e1e5c670bf1358,
title = "Advocating the need of a systems biology approach for personalised prognosis and treatment of B-CLL patients",
abstract = "The clinical course of B-CLL is heterogeneous. This heterogeneity leads to a clinical dilemma: can we identify those patients who will benefit from early treatment and predict the survival? In recent years, mathematical modelling has contributed significantly in understanding the complexity of diseases. In order to build a mathematical model for determining prognosis of B-CLL one has to identify, characterise and quantify key molecules involved in the disease. Here we discuss the need and role of mathematical modelling in predicting B-CLL disease pathogenesis and suggest a new systems biology approach for a personalised therapy of B-CLL patients.",
author = "Hemanth Tummala and Alexey Goltsov and Khalil, {Hilal S.} and Anne Sproul and Fiona Scott and Vanio Mitev and Nikolai Zhelev",
year = "2012",
month = "12",
day = "30",
doi = "10.7750/BioDiscovery.2012.6.4",
language = "English",
volume = "6",
journal = "BioDiscovery",
issn = "2050-2966",
number = "4",

}

Advocating the need of a systems biology approach for personalised prognosis and treatment of B-CLL patients. / Tummala, Hemanth; Goltsov, Alexey; Khalil, Hilal S.; Sproul, Anne; Scott, Fiona; Mitev, Vanio; Zhelev, Nikolai.

In: BioDiscovery, Vol. 6, No. 4, 30.12.2012.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Advocating the need of a systems biology approach for personalised prognosis and treatment of B-CLL patients

AU - Tummala, Hemanth

AU - Goltsov, Alexey

AU - Khalil, Hilal S.

AU - Sproul, Anne

AU - Scott, Fiona

AU - Mitev, Vanio

AU - Zhelev, Nikolai

PY - 2012/12/30

Y1 - 2012/12/30

N2 - The clinical course of B-CLL is heterogeneous. This heterogeneity leads to a clinical dilemma: can we identify those patients who will benefit from early treatment and predict the survival? In recent years, mathematical modelling has contributed significantly in understanding the complexity of diseases. In order to build a mathematical model for determining prognosis of B-CLL one has to identify, characterise and quantify key molecules involved in the disease. Here we discuss the need and role of mathematical modelling in predicting B-CLL disease pathogenesis and suggest a new systems biology approach for a personalised therapy of B-CLL patients.

AB - The clinical course of B-CLL is heterogeneous. This heterogeneity leads to a clinical dilemma: can we identify those patients who will benefit from early treatment and predict the survival? In recent years, mathematical modelling has contributed significantly in understanding the complexity of diseases. In order to build a mathematical model for determining prognosis of B-CLL one has to identify, characterise and quantify key molecules involved in the disease. Here we discuss the need and role of mathematical modelling in predicting B-CLL disease pathogenesis and suggest a new systems biology approach for a personalised therapy of B-CLL patients.

U2 - 10.7750/BioDiscovery.2012.6.4

DO - 10.7750/BioDiscovery.2012.6.4

M3 - Article

VL - 6

JO - BioDiscovery

JF - BioDiscovery

SN - 2050-2966

IS - 4

ER -